Octave
Menlo Park · Founded 2014
About Octave
Octave develops and offers a blood-based diagnostic platform focused on measuring disease activity in neurodegenerative conditions. It provides the Octave MSDA Test, a multi-analyte biomarker assay that quantifies levels of multiple proteins to assess activity in multiple sclerosis. The company supports clinicians and patients by transforming biomarker data into individualized reports that inform treatment decisions. It continues to expand research into additional biomarkers and disease progression models in neurodegeneration.
Company Facts
- Founded: 2014
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $1K – $10K
- Total funding: $142.1M
- Funding stage: Late Stage Venture
- Last round: Grant (Oct 2025)
- Website: http://www.octavebio.com
- Phone: 6504590942
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/octave-14996 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.